Venkatraman Seshan

17PUBLICATIONS
177CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis.

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Jul 17, 2025
Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.

Raphael Steiner, Liana Nikolaenko, Ranjit Nair

|Jun 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants.

Paola Ghione, Diana Mandelker, Maria Arcila

Pageof 3

Frequent Collaborators

7 joint publications

Gilles Salles

7 joint publications

Ahmet Dogan

5 joint publications

Ariela Noy

5 joint publications

Connie Lee Batlevi